SHANGHAI PHARMACEUTICALS HOLDING revenue breakdown overview

SHANGHAI PHARMACEUTICALS HOLDING revenue for the last year amounted to 260.30 B CNY, the most of which — 228.35 B CNY — came from its highest performing source at the moment, Distribution, the year earlier bringing 200.75 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI PHARMACEUTICALS HOLDING 255.97 B CNY, and the year before that — 228.38 B CNY.